Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert N McBurney

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|December 13, 2005
Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacologyJan van der Greef, Robert N McBurney
Pharmacogenomics|October 24, 2006
Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?Jan van der Greef, Thomas Hankemeier, Robert N McBurney
BMC Bioinformatics|September 7, 2010
Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithmsYu Guo, Armin Graber, Robert N McBurney, et al.
Drug Discovery Today. Technologies|July 2, 2014
Lost in translation? Role of metabolomics in solving translational problems in drug discovery and developmentJan van der Greef, Aram Adourian, Pieter Muntendam, et al.
The Patient|April 27, 2021
Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future DirectionsW Benjamin Nowell, Peter A Merkel, Robert N McBurney, et al.
Multiple Sclerosis and Related Disorders|January 5, 2025
Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosisFarren B S Briggs, Hollie Schmidt, Farrah J Mateen, et al.
ACR Open Rheumatology|May 1, 2023
Engaging Multistakeholder Perspectives to Identify Patient-Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune ConditionsShilpa Venkatachalam, Kelly Gavigan, Shubhasree Banerjee, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Journal of Medical Internet Research|September 12, 2022
Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness TrialLouisa G Sylvia, Mitchell R Lunn, Juno Obedin-Maliver, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|December 13, 2005
Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacologyJan van der Greef, Robert N McBurney
Pharmacogenomics|October 24, 2006
Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?Jan van der Greef, Thomas Hankemeier, Robert N McBurney
BMC Bioinformatics|September 7, 2010
Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithmsYu Guo, Armin Graber, Robert N McBurney, et al.
Drug Discovery Today. Technologies|July 2, 2014
Lost in translation? Role of metabolomics in solving translational problems in drug discovery and developmentJan van der Greef, Aram Adourian, Pieter Muntendam, et al.
The Patient|April 27, 2021
Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future DirectionsW Benjamin Nowell, Peter A Merkel, Robert N McBurney, et al.
Multiple Sclerosis and Related Disorders|January 5, 2025
Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosisFarren B S Briggs, Hollie Schmidt, Farrah J Mateen, et al.
ACR Open Rheumatology|May 1, 2023
Engaging Multistakeholder Perspectives to Identify Patient-Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune ConditionsShilpa Venkatachalam, Kelly Gavigan, Shubhasree Banerjee, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Journal of Medical Internet Research|September 12, 2022
Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness TrialLouisa G Sylvia, Mitchell R Lunn, Juno Obedin-Maliver, et al.
Pageof 1